Related Experiment Video
Updated: Jun 15, 2026
Detecting Anastasis In Vivo by CaspaseTracker Biosensor
Published on: February 1, 2018
On the death Trk
Liraz Harel1, Barbara Costa, Mike Fainzilber
1Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel.
Abstract:
The trk family of receptor tyrosine kinases supports survival and differentiation in the nervous system. Paradoxically it has also been shown that members of the trk family can induce cell death in pediatric tumor cells of neuronal origin. Moreover, TrkA and TrkC serve as good prognostic indicators in neuroblastoma and medulloblatoma, respectively. Although the possible linkage between these observations was intriguing, until recently there was limited insight on the mechanisms involved. Recent findings suggest that TrkA might influence neuronal cell death through stimulation of p75 cleavage. An alternative p75-independent mechanism was suggested by a newly discovered interaction between TrkA and CCM2 (the protein product of the gene cerebral cavernous malformation 2). Coexpression of CCM2 with TrkA induces cell death in medulloblastoma and neuroblastoma cells, and CCM2 expression levels correlate with those of TrkA and with good prognosis in neuroblastoma patients. Thus, mechanistic clues to the enigma of trk-induced cell death have begun to emerge. Detailed elucidation of these mechanisms and their in vivo physiological significance will be of keen interest for future research.
Insights
Receptor tyrosine kinases (RTKs) in the Trk family paradoxically promote neuronal survival and induce cell death in pediatric tumors. New research reveals TrkA interaction with CCM2 protein may mediate this cell death, offering prognostic insights.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- The Trk family of receptor tyrosine kinases (RTKs) is crucial for nervous system development, supporting neuronal survival and differentiation.
- Paradoxically, Trk family members can also induce cell death in pediatric tumor cells of neuronal origin, such as neuroblastoma and medulloblastoma.
- TrkA and TrkC are established as favorable prognostic indicators in neuroblastoma and medulloblastoma, respectively, suggesting a complex role in these cancers.
Purpose of the Study:
- To investigate the mechanisms underlying the paradoxical induction of cell death by Trk family members in neuronal tumor cells.
- To explore the potential link between TrkA signaling and cell death pathways, including p75-dependent and independent mechanisms.
- To elucidate the role of the novel TrkA-CCM2 interaction in Trk-mediated cell death and its clinical relevance in neuroblastoma.
Main Methods:
- Review of recent findings on TrkA signaling pathways involved in neuronal cell death.
- Analysis of the interaction between TrkA and CCM2 (cerebral cavernous malformation 2) protein.
- Examination of cell death induction in medulloblastoma and neuroblastoma cell lines upon coexpression of CCM2 and TrkA.
- Correlation analysis of CCM2 expression levels with TrkA expression and patient prognosis in neuroblastoma.
Main Results:
- Recent studies suggest TrkA may induce neuronal cell death via stimulation of p75 cleavage.
- A novel, p75-independent mechanism involving TrkA interaction with CCM2 has been identified.
- Coexpression of CCM2 with TrkA triggers cell death in medulloblastoma and neuroblastoma cells.
- CCM2 expression levels positively correlate with TrkA levels and favorable prognosis in neuroblastoma patients.
Conclusions:
- Emerging evidence points to TrkA-CCM2 interaction as a key mechanism in Trk-induced neuronal cell death.
- This interaction provides mechanistic insights into the dual role of Trk signaling in neuronal development and cancer.
- Further research into these mechanisms and their in vivo significance is warranted for potential therapeutic applications in neuroblastoma and medulloblastoma.
Related Concept Videos
01:21Kubler Ross's Stages of Dying
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from emotional distress. Anger...
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:18Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:17The Extrinsic Apoptotic Pathway
01:30Apoptosis
01:09Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.